ALFA Finder India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold Telegram alerts alfafinder.com →
Saturday, 21 November 2026 Every NSE & BSE earnings call, live and summarised
ALFA Concalls Every earnings call, live and summarised

Earnings calls

Jubilant Pharmova concalls

Every Jubilant Pharmova earnings call we streamed: the live audio and our summary of what management said.

Calls

Mon, 16 Nov

Jubilant Pharmova

JUBLPHARMAQ2 FY27 earnings call

Revenue rose 21% YoY to ₹2,370 Cr, but PAT was only ₹31 Cr as margins fell on Montreal losses (>₹80 Cr in Q2). Management guides H2 mid-teen margins and deferred FY28 guidance.

Summary ready

Q2 FY27: key takeaways

Call page →

Revenue rose 21% YoY to ₹2,370 Cr, but PAT was only ₹31 Cr as margins fell on Montreal losses (>₹80 Cr in Q2). Management guides H2 mid-teen margins and deferred FY28 guidance.

Outlook

H2 average EBITDA margin mid-teens; FY27 capex ₹1,800–1,900 Cr, FY28 ~₹1,000 Cr; net debt ~₹4,000 Cr end-FY27.

Earlier call summaries

All →

Jubilant Pharmova Ltd: key numbers

Share price
₹935.05
Market cap
₹14,894 Cr
Revenue (annual)
₹8,280 Cr
Net profit (annual)
₹398.5 Cr
P/E (TTM)
56.6×Sector 49.0×
Promoter holding
47.68%+0.00% QoQ
FII holding
15.37%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.